Page last updated: 2024-10-27

fluorouracil and Articulation Disorders

fluorouracil has been researched along with Articulation Disorders in 1 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Articulation Disorders: Disorders of the quality of speech characterized by the substitution, omission, distortion, and addition of phonemes.

Research Excerpts

ExcerptRelevanceReference
"Capecitabine plus lapatinib combination is an effective chemotherapy regimen in patients with advanced breast cancer."7.81Reversible slurred speech related to capecitabine and lapatinib combination in patients with breast cancer. ( Akça, Z; Büyükçelik, A; Erden, A; Mutlu, H, 2015)
"Capecitabine plus lapatinib combination is an effective chemotherapy regimen in patients with advanced breast cancer."3.81Reversible slurred speech related to capecitabine and lapatinib combination in patients with breast cancer. ( Akça, Z; Büyükçelik, A; Erden, A; Mutlu, H, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mutlu, H1
Büyükçelik, A1
Akça, Z1
Erden, A1

Other Studies

1 other study available for fluorouracil and Articulation Disorders

ArticleYear
Reversible slurred speech related to capecitabine and lapatinib combination in patients with breast cancer.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2015, Volume: 21, Issue:1

    Topics: Antineoplastic Agents; Articulation Disorders; Breast Neoplasms; Capecitabine; Deoxycytidine; Drug T

2015